Relapsed Myeloma, Treatment for Relapsed MM, Drugs in Development
NLB 2017
(click on the image above to view the video)
Recorded at the IMF Satellite Symposium that was held at the May 2017 Oncology Nursing Society’s annual meeting, this video is the third in a three-part series on myeloma nursing. In this segment, Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN (Taussig Cancer Insitute, Cleveland Clinic, Cleveland, OH) and Charise Gleason, MSN, NP-BC, AOCNP discuss relapsed myeloma, treatment for relapsed MM, and drugs in development.
- Multiple Myeloma Background
- Bone and Renal Health
- Relapsed Myeloma, Treatment for Relapsed MM, Drugs in Development
This activity is supported by educational grants from Celgene Corporation, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, and Bristol-Myers Squibb.
Previous Post
Bone and Renal Health
Next Post
In the field of myeloma, what is the IMWG Summit?




